Form 8-K - Current report:
SEC Accession No. 0001193125-25-125866
Filing Date
2025-05-23
Accepted
2025-05-23 16:26:52
Documents
13
Period of Report
2025-05-23
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d854335d8k.htm   iXBRL 8-K 30964
2 EX-10.1 d854335dex101.htm EX-10.1 56220
  Complete submission text file 0001193125-25-125866.txt   222269

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA clym-20250523.xsd EX-101.SCH 2842
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE clym-20250523_lab.xml EX-101.LAB 18738
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE clym-20250523_pre.xml EX-101.PRE 11702
15 EXTRACTED XBRL INSTANCE DOCUMENT d854335d8k_htm.xml XML 3766
Mailing Address 20 WILLIAM STREET SUITE 145 WELLESLEY HILLS MA 02481
Business Address 20 WILLIAM STREET SUITE 145 WELLESLEY HILLS MA 02481 1-866-857-2596
Climb Bio, Inc. (Filer) CIK: 0001768446 (see all company filings)

EIN.: 832273741 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40708 | Film No.: 25982736
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)